Compounds such as enzyme activity modulators (activators and inhibitors) are important tools to study an enzyme’s role in key cell signaling pathways and enzymatic reactions. SignalChem offers one of the most comprehensive ranges of biologically active recombinant enzymes as well as a broad range of high- quality/low-cost enzyme activators and inhibitors of different classes of enzymes including protein kinases, phosphatases, and epigenetic enzymes. These compounds would enable scientists to study cell signaling pathways and facilitate enzyme research and drug discovery projects.
Name | Catalog Number | CAS Registration Number | Molecular Formula | Purity | Chemical Name |
2’-Deoxy-5-fluorocytidine | D353-904D | 10356-76-0 | C9H12FN3O4 | >98% | 5-Fluoro-2’-deoxycytidine; FCDR; FdCyd; NSC-48006 |
5-Azacytidine | D353-904 | 320-67-2 | C8H12N4O5 | >98% (TLC) | 4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one, Ladakamycin |
AK-7 | S36-904 | 420831-40-9 | C19H21BrN2O3S | 98% (TLC) | N-(3-Bromophenyl)-3-[(hexahydro-1H-azepin-1-yl)sulfonyl]benzamide |
APICIDIN | H83-904B | 183506-66-3 | C34H49N5O6 | ≥98% | Cyclo[(2S)-2-Amino-8-oxodecanoyl-1-methoxy-L-tryptophyl-L-isoleucyl-(2R)-2-piperidinecarbonyl] |
BIX-01294 3HCl | S344-903 | 935693-62-2 | C28H38N6O2.3HCl | >98% | 2-(Hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-6,7-dimethoxy-N-[1-(phenylmethyl)-4-piperidinyl]-4-quinazolinamine trihydrochloride |
BML-210 | H83-904C | 537034-17-6 | C20H25N3O2 | 98% | N1-(2-aminophenyl)-N8-phenyloctanediamide |
C-646 | K311-903 | 328968-36-1 | C24H19N3O6 | >98% | 4-[4-[[5-(4,5-Dimethyl-2-nitrophenyl)-2-furanyl]methylene]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzoic acid |
Chaetocin | K421-904C | 28097-03-2 | C30H28N6O6S4 | >99% | Lys methyltransferase inhibitor |
CPTH2 | K311-903B | 357649-93-5 | C14H14ClN3S | >98% (TLC) | Cyclopentylidene-[4-(4’-chlorophenyl)thiazol-2-yl]hydrazone |
CUDC-101 | H83-904 | 1012054-59-9 | C24H26N4O4 | >99% (HPLC) | 7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide |
Daminozide | K421-904B | 1596-84-5 | C6H12N2O3 | 98% | 1-(2,2-Dimethylhydrazide)butanedioic acid |
Decitabine | D353-904B | 2353-33-5 | C8H12N4O4 | >98% | 5-Aza-2’-deoxycytidine; NSC-127716 |
DMOG | J48-904 | 89464-63-1 | C6H9NO5 | >98% | N-(2-Methoxy-2-oxoacetyl)glycine methyl ester; Dimethyloxalylglycine |
EX-527 | S35-904F | 49843-98-3 | C13H13ClN2O | 98% (TLC) | 6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide (racemic) |
Garcinol | K311-903C | 78824-30-3 | C38H50O6 | >97% (TLC) | Camboginol, 3-(3,4-dihydroxybenzoyl)-4-hydroxy-8,8-dimethyl-1,7-bis(3-methyl-2-buten-1-yl)-5-[(2S)-5-methyl-2-(1-methylethenyl)-4-hexen-1-yl]-bicyclo[3.3.1]non-3-ene-2,9-dione |
GSK-J1 (Free acid) | J48-904B | 1373422-53-7 | C22H23N5O2 | 99% | N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine |
GSK-J4 (ethylester) | J48-904C | 1373423-53-0 | C24H27N5O2 | >99% | N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine ethyl ester |
HPA (HEXYL-4-PENTYNOIC ACID) | H83-904D | 96017-59-3 | C11H18O2 | >97% (TLC) | 2-(2-propynyl)octanoic acid (racemic); HPA |
IOX1 (8H5QCA) | J48-904D | 5852-78-8 | C10H7NO3 | >98% (HPLC) | 5-Carboxy-8-hydroxyquinoline, 8-Hydroxy-5-quinolinecarboxylic acid |
ML-324 | J48-904E | 1222800-79-4 | C21H23N3O2 | >98% (TLC) | N-(3-(dimethylamino)propyl)-4-(8-hydroxyquinolin-6-yl)benzamide |
MS-275 (Entinostat) | H83-904E | 209783-80-2 | C21H20N4O3 | >98% (TLC) | Pyridin-3-ylmethyl 4-((2-aminophenyl)carbamoyl)benzylcarbamate; Entinostat |
Panobinostat | H83-904G | 404950-80-7 | C21H23N3O2 | >98% (TLC) | (E)-N-hydroxy-3-(4-((2-(2-methyl-1H-indol-3-yl)ethylamino)methyl)phenyl) crylamide; LBH-589 |
Phenylbutyrate NA | H83-904H | 1716-12-7 | C10H11NaO2 | >98% (TLC; 5% CH3OH in CH2Cl2, Rf=0.36) | 4-Phenylbutyric acid, sodium salt |
RG-108 | D353-904C | 48208-26-0 | C19H14N2O4 | >98% (TLC) | N-Phthalyl-L-tryptophan |
Romidepsin (FK228) | H83-904I | 128517-07-7 | C24H36N4O6S2 | >98% (HPLC) | Cyclo[(2Z)-2-amino-2-butenoyl-L-valyl-(3S,4E)-3-hydroxy-7-mercapto-4-heptenoyl-D-valyl-D-cysteinyl], cyclic (3-5) disulfide |
Sirtinol | S35-904B | 410536-97-9 | C26H22N2O2 | >98% (TLC) | 2-[[(2-Hydroxy-1-naphthalenyl)methylene]amino]-N-(1-phenylethyl)benzamide |
Splitomicin | S35-904G | 5690-03-09 | C13H10O2 | >98% (TLC) | 1,2-Dihydro-3H-naphtho[2,1-b]pyran-3-one |
TC-E 5003 | P3695-903 | 17328-16-4 | C16H14Cl2N2O4S | >98% (TLC) | N,N’-(Sulfonyldi-4,1-phenylene)bis(2-chloroacetamide) |
Tranylcypromine | K421-904 | 13492-01-8 | C9H11N · 1/2H2SO4 | >98% (TLC) | Trans (±)-2-phenylcyclopropanamine; 2-PCPA |
Trichostatin A | H83-904J | 58880-19-6 | C17H22N2O3 | >99% | (2E,4E,6R)-7-(4-(Dimethylamino)phenyl)-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide |
Tubastatin A · HCL | H83-904K | 1239262-52-2 | C20H21N3O2·HCl | 99% (HPLC) | N-hydroxy-4-((2-methyl-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)methyl)benzamide hydrochloride |
UNC1999 | D353-904E | 1431612-23-5 | C33H43N7O2 | >98% (HPLC) | N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-1-propan-2-yl-6-[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]indazole-4-carboxamide |
Valproate NA | H83-904L | 1069-66-5 | C8H15NaO2 | >98% (TLC) | Sodium 2-propylpentanoate |
Vorinostat (SAHA) | H83-904M | 149647-78-9 | C14H20N2O3 | >98% | N-Hydroxy-N’-phenyloctanediamide |
STAY CONNECTED
Fax: 1-604-232-4601